Skip to main content
SpringerLink
Log in

Identification ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptopyruvic acid with a metabolic intermediate betweenS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine andS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptolactic acid

  • Full Papers
  • Published:
Amino Acids Aims and scope Submit manuscript

Summary

S-[2-Carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptopyruvic acid (I) was chemically synthesized in 15% yield by incubating a reaction mixture oftrans-urocanic acid and 3-fold excess of 3-mercaptopyruvic acid at 45°C for 6 days. The synthesized compound was characterized by fast-atom-bombardment mass spectrometry and high-voltage paper electrophoresis. CompoundI was identified with a product of an enzymatic reaction ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine (II) with rat liver homogenate in a phosphate buffer, pH 7.4. CompoundI was degraded toS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptolactic acid (III), a compound previously found in human urine [Kinuta et al. (1994) Biochem J 297: 475–478], by incubation with rat liver homogenate. From these results, we suggest that compoundI is a metabolic intermediate for the formation of compoundIII from compoundII. The present pathway follows a formation of compoundII fromS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl] gluthathione [Kinuta et al. (1993) Biochim Biophys Acta 1157: 192–198], a proposed metabolite ofl-histidine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barden HP, Pathak MA (1967) The metabolism and function of urocanic acid in skin. J Invest Dermatol 48: 11–17

    PubMed  Google Scholar 

  • Kinuta M, Yao K, Masuoka N, Ohta J, Teraoka, T, Ubuka T (1991a) Isolation and characterization of 3-[(carboxymethyl)thio]-3-(1H-imidazol-4-yl)propanoic acid from human urine and preparation of its proposed precursor,S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]cysteine. Biochem J 275: 617–621

    PubMed  Google Scholar 

  • Kinuta M, Masuoka N, Yao K, Ohta J, Yoshida S, Futani S, Ubuka T (1991b)S-[2-Carboxy-1-(1H-imidazol-4-yl)ethyl] cysteine in normal human urine. Amino Acids 1: 259–262

    Google Scholar 

  • Kinuta M, Ubuka T, Yao K, Futani S, Fujiwara M, Kurozumi Y (1992) Isolation ofS-[2carboxy-1-(1H-imidazol-4-yl)ethyl]cysteine from human urine. Biochem J 283: 39–40

    PubMed  Google Scholar 

  • Kinuta M, Ubuka T, Yao K, Yamada S, Yukihiro K, Tomozawa M (1993) Preparation and characterization ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl] glutathione and its derivatives as proposed precursors ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]cys-teine, a compound found in human urine. Biochim Biophys Acta 1157: 192–198

    PubMed  Google Scholar 

  • Kinuta M, Ubuka T, Yao W-B, Zhao Y-O, Shimizu H (1994) Isolation ofS-[2-carboxy-1-(1H-imidazol -4-yl)ethyl]-3-thiolactic acid, a new metabolite of histidine, from normal human urine and its formation fromS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]cysteine. Biochem J 297: 475–478

    PubMed  Google Scholar 

  • Kinuta M, Sasaki K, Shimizu H, Ubuka T (1996) Isolation and characterization ofN-acetyl-S-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine, a new metabolite of histidine, from normal human urine and its formation fromS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine. Biochim Biophys Acta 1291: 131–137

    PubMed  Google Scholar 

  • Macpherson HT (1946) The basic amino-acid content of proteins. Biochem J 40: 470–481

    Google Scholar 

  • Pauly H (1904) Über die Konstitution des Histidins: I, Mitteilung. Hoppe-Seyler's Z Physiol Chem 42: 508–518

    Google Scholar 

  • Scott IR (1981) Factors controling the expressed activity of histidine ammonia-lyase in the epidermis and the resulting accumulation of urocanic acid. Biochem J 194: 829–838

    PubMed  Google Scholar 

  • Toennis G, Kolb JJ (1951) Techniques and reagents for paper chromatography. Anal Chem 23: 823–826

    Google Scholar 

  • Ubuka T (1962) Identification of isovalthine and its related compounds. J Biochem (Tokyo) 52: 440–443

    Google Scholar 

  • Ubuka T, Ohta J, Akagi R, Hosaki Y, Ishimoto Y, Kiguchi S, Ikeda T, Ishino K (1992) Metabolism ofl-cysteine via transamination pathway (3-mercaptopyruvate pathway). Amino Acids 3:243–252

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Okayama University Medical School, 2-5-1 Shikata-cho, 700, Okayama, Japan

    M. Kinuta, H. Shimizu, N. Masuoka, J. Ohta, W. -B. Yao & T. Ubuka

Authors
  1. M. Kinuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Masuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Ohta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. -B. Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Ubuka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kinuta, M., Shimizu, H., Masuoka, N. et al. Identification ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptopyruvic acid with a metabolic intermediate betweenS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine andS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptolactic acid. Amino Acids 13, 163–169 (1997). https://doi.org/10.1007/BF01373214

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01373214

Keywords

Search

Navigation